Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of escalating doses of SKI-O-703 in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SKI-O-703 (SKI-O-703)

Snippet

Sponsor: Oscotec Inc. | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED